CAD 7.5
(-1.96%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | - CAD | -105.88% |
2022 | - CAD | -113.71% |
2021 | - CAD | 288.92% |
2020 | - CAD | -359.83% |
2019 | - CAD | 209.66% |
2018 | - CAD | -91.14% |
2017 | - CAD | 4.14% |
2016 | - CAD | -33.03% |
2015 | - CAD | 732.59% |
2014 | - CAD | 161.04% |
2013 | - CAD | 203.38% |
2012 | - CAD | -350.18% |
2011 | -46.58 Thousand CAD | 72.71% |
2010 | -170.67 Thousand CAD | -571.84% |
2009 | - CAD | 103.37% |
2008 | -1.07 Million CAD | 92.9% |
2007 | - CAD | -147.05% |
2006 | 28.78 Million CAD | -21.91% |
2005 | 41.15 Million CAD | 93.89% |
2004 | 21.22 Million CAD | 3434.32% |
2003 | 600.6 Thousand CAD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -1.15 Million CAD | 0.0% |
2024 Q1 | -1.15 Million CAD | -133.74% |
2023 Q1 | 1.09 Million CAD | 340.83% |
2023 Q2 | 1.09 Million CAD | 0.0% |
2023 Q3 | -492.24 Thousand CAD | -144.96% |
2023 Q4 | -492.24 Thousand CAD | 0.0% |
2023 FY | - CAD | -105.88% |
2022 Q3 | -454.66 Thousand CAD | -158.44% |
2022 Q1 | 777.96 Thousand CAD | 290.17% |
2022 FY | - CAD | -113.71% |
2022 Q4 | -454.66 Thousand CAD | 0.0% |
2022 Q2 | 777.96 Thousand CAD | -0.0% |
2021 Q1 | -1.83 Million CAD | -192.6% |
2021 Q4 | -409.09 Thousand CAD | 0.0% |
2021 Q3 | -409.09 Thousand CAD | 77.74% |
2021 Q2 | -1.83 Million CAD | 0.0% |
2021 FY | - CAD | 288.92% |
2020 Q3 | -628.06 Thousand CAD | -135.88% |
2020 FY | - CAD | -359.83% |
2020 Q2 | 1.75 Million CAD | 0.0% |
2020 Q1 | 1.75 Million CAD | 253.35% |
2020 Q4 | -628.06 Thousand CAD | 0.0% |
2019 Q1 | 702.05 Thousand CAD | 473.45% |
2019 Q3 | -1.14 Million CAD | -262.58% |
2019 FY | - CAD | 209.66% |
2019 Q4 | -1.14 Million CAD | 0.0% |
2019 Q2 | 702.05 Thousand CAD | -0.0% |
2018 Q2 | -243.44 Thousand CAD | 0.0% |
2018 FY | - CAD | -91.14% |
2018 Q4 | 122.42 Thousand CAD | 0.0% |
2018 Q3 | 122.42 Thousand CAD | 150.29% |
2018 Q1 | -243.44 Thousand CAD | 84.81% |
2017 Q3 | -1.6 Million CAD | -1720.81% |
2017 Q4 | -1.6 Million CAD | 0.0% |
2017 FY | - CAD | 4.14% |
2017 Q1 | -88.01 Thousand CAD | 96.64% |
2017 Q2 | -88.01 Thousand CAD | 0.0% |
2016 Q3 | -2.62 Million CAD | -351.83% |
2016 Q4 | -2.62 Million CAD | 0.0% |
2016 Q2 | 1.04 Million CAD | -0.0% |
2016 Q1 | 1.04 Million CAD | 272.51% |
2016 FY | - CAD | -33.03% |
2015 Q1 | -1.68 Million CAD | -6.86% |
2015 Q4 | -603.82 Thousand CAD | 0.0% |
2015 Q3 | -603.82 Thousand CAD | 64.17% |
2015 FY | - CAD | 732.59% |
2015 Q2 | -1.68 Million CAD | 0.0% |
2014 Q3 | -1.57 Million CAD | -92.26% |
2014 Q2 | -820.27 Thousand CAD | 0.0% |
2014 FY | - CAD | 161.04% |
2014 Q1 | -820.27 Thousand CAD | -64.26% |
2014 Q4 | -1.57 Million CAD | 0.0% |
2013 Q3 | -499.36 Thousand CAD | -436.46% |
2013 FY | - CAD | 203.38% |
2013 Q1 | 148.41 Thousand CAD | 0.0% |
2013 Q2 | 148.41 Thousand CAD | -0.0% |
2013 Q4 | -499.36 Thousand CAD | 0.0% |
2012 FY | - CAD | -350.18% |
2011 FY | - CAD | 72.71% |
2010 FY | - CAD | -571.84% |
2009 FY | - CAD | 103.37% |
2008 FY | - CAD | 92.9% |
2007 FY | - CAD | -147.05% |
2006 FY | - CAD | -21.91% |
2005 FY | - CAD | 93.89% |
2004 FY | - CAD | 3434.32% |
2003 FY | - CAD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Healwell AI Inc. | -16.11 Million CAD | 100.0% |
Canadian Banc Corp | - CAD | NaN% |
Enbridge Inc | 16.31 Billion CAD | 100.0% |
Enbridge Inc | 16.31 Billion CAD | 100.0% |
Enbridge Inc | 16.31 Billion CAD | 100.0% |
NORTH AMERICAN FIN 15 SPLIT COR | - CAD | NaN% |
Financial 15 Split Corp | - CAD | NaN% |
Great-West Lifeco Inc | 3.99 Billion CAD | 100.0% |
Manulife Financial Corp | 4.76 Billion CAD | 100.0% |
Manulife Financial Corp | 4.09 Billion CAD | 100.0% |
Power Corporation of Canada | 475 Million CAD | 100.0% |
TransAlta Corp | 1.71 Billion CAD | 100.0% |
The Toronto-Dominion Bank 5 YR RST PFD 1 | -2.37 Billion CAD | 100.0% |
The Toronto-Dominion Bank NCUM 5Y PFD SR18 | -2.37 Billion CAD | 100.0% |
TC ENERGY CORP PREF SERIES 7 | 9.37 Billion CAD | 100.0% |
Veren Inc. | 2.27 Billion CAD | 100.0% |